ERK-CLIPTAC

N/A

Report date: 2023/03/01 09:50:50
NME

Base Information

Drug NameERK-CLIPTAC
Drug Alias NameERK-CLIPTAC
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionMitogen-activated protein kinase; ERK1/ERK2 inhibitorsCereblon modulators
TargetsMitogen-activated protein kinase; ERK1/ERK2Cereblon
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstex Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A